An enhanced model that integrates non-AJCC clinical features provides clinicians with a more accurate tool for identifying high-risk patients with MCC.
Researchers explored the link between cancer stage at diagnosis and survival outcomes for non-Hispanic Black patients with gastrointestinal cancers.